Drug Safety News
Xolair Expanded Indication
Now approved for patients 6 years and older...
[MORE INFORMATION]
Syndros Oral Solution Approved
A medication to treat anorexia for cancer patients...
[MORE INFORMATION]
Syndros Oral Solution Approved
A medication to treat anorexia for cancer chemotherapy patients...
[MORE INFORMATION]
FDA Approves Epclusa
Epclusa was approved to treat patients with chronic hepatitis C...
[MORE INFORMATION]
FDA Approves Sabril
An anticonvulsant medication was approved...
[MORE INFORMATION]
Canagliflozin Safety Communication Update
Drug labels have been revised to include new warnings...
[MORE INFORMATION]
Zecuity Safety Communication Update
Teva Pharmaceuticals is investigating the cause of Zecuity patch burns...
[MORE INFORMATION]
Immodium Safety Communication
FDA warns about serious health problems with higher than recommended dose...
[MORE INFORMATION]
FDA Approves Probuphine
FDA approves the first buprenorphine implant...
[MORE INFORMATION]
Nizoral Safety Communication
FDA is warning health care professionals to avoid prescribing the antifungal medicine...
[MORE INFORMATION]
Olanzapine Safety Communication
FDA is warning about a rare but serious skin reaction that can progress to affect other parts of the body...
[MORE INFORMATION]
Aripiprazole Safety Announcement
FDA is warning that compulsive or uncontrollable urges have been reported...
[MORE INFORMATION]
Aripiprazole Safety Announcement
FDA is warning that compulsive or uncontrollable urges have been reported...
[MORE INFORMATION]
Brintellix Name Change Announcement
The new brand name will be Trintellix to decrease prescribing and dispensing errors...
[MORE INFORMATION]
FDA Approves Nuplazid
The first drug with approval to treat hallucinations and delusions associated with Parkinson's Disease...
[MORE INFORMATION]
Diflucan Safety Announcement
There is a possible increased risk of miscarriage with the use of oral fluconazole...
[MORE INFORMATION]
Saxagliptin and Alogliptin Safety Communication
These type 2 diabetes medications may increase risk of heart failure...
[MORE INFORMATION]
FDA Approves Inflectra
The second biosimilar has been approved by the FDA...
[MORE INFORMATION]
FDA Approves Cinqair
Approved to treat severe asthma...
[MORE INFORMATION]
Opioid Safety Announcement
The FDA is warning about several safety issues with opioids...
[MORE INFORMATION]
FDA Approves Taltz
Approved to treat adults with plaque psoriasis...
[MORE INFORMATION]
Prilosec Expanded Indication
New indication includes treatment in pediatric patients...
[MORE INFORMATION]
Discontinuation of Valsartan Tablets
Sandoz, Inc reported to the FDA the discontinuation...
Discontinuation of Valsartan and Hydrochlorotiazide Tablets
Sandoz, Inc reported to the FDA the discontinuation...
Discontinuation of Memantine Hydrochloride XR Capsules
As reported to the FDA...
FDA Approves Zepatier
Approved for the treatment of chronic hepatitis C genotypes 1 and 4...
Licorice Coughing Liquid Recall
This product was found to contain an undeclared prescription drug...
Children's Guaifenesin Liquid Recall
As a result of a potential defect with the dosage cup...